These projects explore multiple intersecting obstacles—economic, geographic, systemic, and social—to access to medications and care access across multiple communities. Leveraging advanced data methods, community partnerships, and policy analysis, our projects examine how insurance dynamics, healthcare infrastructure, prescribing differences, and affordability factors influence treatment initiation and ongoing care. These projects aim to identify actionable solutions that improve medication access and health outcomes across populations.
Access to Care and Drug Shortages Research Projects
Human vs. Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings
Funder: The Leona M. and Harry B. Helmsley Charitable Trust; PI: Luo
This study compares the effectiveness, safety, and affordability of human versus analogue insulin in youth with type 1 diabetes living in low-resource settings, with the goal of guiding treatment decisions and improving access to optimal care.
Impact of COVID-19 on Drug Shortages
Funder: AHRQ; PI: Suda
This study examines how the COVID‑19 pandemic disrupted drug supply chains in the U.S. and Canada, revealing a sharp surge in shortages—especially for injectable, generic, and essential medications—between February and April 2020. The research links these shortages to treatment interruptions and adverse clinical outcomes, highlighting vulnerabilities in global pharmaceutical supply chains and informing policy strategies to enhance resilience during future health emergencies